awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58229736-2D7E734F-9F5E-4F93-B6D1-44CF62100189
Q58229736-2D7E734F-9F5E-4F93-B6D1-44CF62100189
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58229736-2D7E734F-9F5E-4F93-B6D1-44CF62100189
Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology
P2860
Q58229736-2D7E734F-9F5E-4F93-B6D1-44CF62100189
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58229736-2D7E734F-9F5E-4F93-B6D1-44CF62100189
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
183dc65482c6c65c3c8cc1a2db9d013f1b349552
P2860
Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance.